Rezolute, Inc. (RZLT)
2.44
-0.05
(-2.01%)
USD |
NASDAQ |
Mar 23, 14:43
Rezolute EPS Diluted (Quarterly) : -0.2196 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| XOMA Royalty Corp. | 0.2586 |
| Silvergate Capital Corp. | -- |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.77M |
| Total Expenses (Quarterly) | 22.77M |
| Enterprise Value | 106.63M |
| Earnings Yield | -37.86% |
| Normalized Earnings Yield | -37.86 |